Skin substitute lot number tracking: what a clinic log should hold
A lot tracking log ties every unit your clinic receives to the identifier on its label, where it was stored and what happened to it: applied to a named patient on a date of service, returned, or discarded. FDA's tracking rule for human tissue sits with the establishments that process and distribute the product, but the chain only reaches the patient if the clinic writes the identifier down. This post sets out what the rule says, what is on the label and the fields a clinic log needs.
What FDA's tracking rule covers
For human cell and tissue products (HCT/Ps), which include amniotic and other human tissue grafts, the rule is 21 CFR 1271.290. As read on 16 November 2026, it applies to anyone who performs "any step in the manufacture of an HCT/P in which you handle the HCT/P". Part 1271 defines manufacture to include storage, labeling, packaging and distribution, so it reaches processors and distributors. Those establishments must:
- keep a tracking system that runs "from the donor to the consignee or final disposition" and back again (1271.290(b));
- label each HCT/P with "a distinct identification code" that relates it to the donor and to all records about it (1271.290(c)). With one stated exception, the code may not include an individual's name, social security number or medical record number;
- record the code and type of each HCT/P sent to a consignee (1271.290(d));
- tell the consignee in writing, at or before distribution, about these requirements and the tracking system they keep (1271.290(f)).
The clinic that receives the product is the consignee in that chain. Section 1271.15(d) says an establishment is not required to comply with Part 1271 if it "does not recover, screen, test, process, label, package, or distribute, but only receives or stores HCT/P's solely for implantation, transplantation, infusion, or transfer within your facility."
Whether that exception fits your practice, and what your state, your accreditor and your payers ask for on top of it, is for your medical director and counsel to decide. This post describes the paperwork. It does not tell you what the law requires of your clinic.
What is on the label
Human tissue products. Under 21 CFR 1271.370(b), the label of an HCT/P made available for distribution must show the distinct identification code, a description of the type of HCT/P and the expiration date, if any. The storage temperature, and the name and address of the establishment that released the product, must be on the label or accompany it (1271.370(c)).
Products regulated as devices. FDA's UDI Basics page says a unique device identifier (UDI) generally consists of a device identifier, which identifies the labeler and the specific version or model, and a production identifier. The production identifier carries the lot or batch number, the serial number, the expiration date or the manufacturing date when those appear on the label. The UDI is printed in plain text and in a machine-readable form that can be scanned into an electronic record. For an HCT/P regulated as a device, the production identifier carries the distinct identification code.
Copy the identifier exactly as printed and note which field it came from: lot, serial number or identification code.
The log, field by field
Keep one row per unit, not one row per box.
| Stage | What to record |
|---|---|
| Receiving | Date received. Supplier and packing slip or invoice number. Product name and size as printed on the label. The identifier for each unit. Expiration date. Condition of the package on arrival. Who received it. |
| Storage | Where the unit is kept. The storage temperature stated on the label or the paperwork that came with it. The date and reason if a unit is set aside and not available for use. |
| Application | Patient. Date of service. Provider. The identifier of the unit used, copied from the label into the procedure note as well. Size, and the amount applied. |
| Any other outcome | Returned, discarded, expired or damaged, with the date, the reason and who recorded it. |
File the supplier's written tracking notice and each packing slip with the receiving records. The fields the provider's note needs at each application are in our wound care documentation checklist.
Every unit gets an outcome
A log that records only applications cannot be reconciled. Each unit received should end in exactly one state: applied, on the shelf, returned or discarded. At a set interval, count what is on the shelf and check the sum:
When the numbers do not match, look first for a unit that was opened and not recorded, or an identifier copied wrongly into the note. How unused product is handled on a claim is a separate question; see our office billing guide.
When a notice names a lot
The purpose of tracking, in the words of 1271.290(a), is "to facilitate the investigation of actual or suspected transmission of communicable disease and take appropriate and timely corrective action." FDA describes a recall as "a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers".
When a manufacturer or supplier sends a notice about a lot, the log should answer three questions quickly:
- Do we hold any units from that lot, and where are they?
- Which patients received units from it, and on which dates of service?
- What happened to every other unit from that lot that we received?
What happens next is for the provider, following the instructions in the notice.
How long the records are kept
Part 1271 requires the establishments it covers to retain the records for a particular HCT/P "at least 10 years after the date of its administration". If that date is not known, the period is at least 10 years after the date of distribution, disposition or expiration, whichever is latest (1271.270(d)). That period applies to those establishments. A clinic's own retention period comes from state medical records law, payer contracts and its own policy. Ask your counsel which applies.
What we keep on our side
Total Wound Experts keeps lot and serial number logs for every graft we ship, and reconciles what was shipped against what was billed each month. If your clinic receives a records request, ask us for the shipping and lot records at the same time so the two sets can be compared.
Related pages
- Wound care documentation checklist
- Skin substitute billing in the office setting
- How clinics order skin substitutes
- Questions to ask a skin substitute supplier
Frequently asked questions
What should a clinic record to track skin substitute lot numbers?
One row per unit: the date received, the supplier and packing slip number, the product name and size, the identifier printed on the label, the expiration date, where the unit is stored and what happened to it. A unit ends as applied to a named patient on a date of service, returned, or discarded.
Does FDA require a clinic to keep a tissue tracking log?
FDA's tracking rule, 21 CFR 1271.290, applies to establishments that perform a manufacturing step in which they handle the product, and manufacture includes distribution. Section 1271.15(d) says an establishment that only receives or stores HCT/Ps for use within its own facility is not required to comply with Part 1271. State law, accreditation standards and payer rules can still call for records, so the decision belongs to your medical director and counsel.
What is the difference between a lot number, a serial number and a UDI?
FDA describes a unique device identifier as a device identifier plus a production identifier. The production identifier is the part that carries the lot or batch number, the serial number and the expiration date when they appear on the label. A lot or batch covers units made under essentially the same conditions; a serial number identifies one specific unit.
How long should lot records be kept?
Part 1271 requires the establishments it covers to keep the records for a particular HCT/P at least 10 years after the date of its administration. A clinic's own retention period is set by state medical records law, payer contracts and its own policy, so ask your counsel.
Sources
Each source below was read on 16 Nov 2026.
- 21 CFR 1271.290, Tracking, eCFR, Office of the Federal Register and Government Publishing Office. Who must track, the distinct identification code, and the written notice to the consignee.
- 21 CFR 1271.15, exceptions from Part 1271, eCFR, Office of the Federal Register and Government Publishing Office. Paragraph (d): establishments that only receive or store HCT/Ps for use within their facility.
- 21 CFR 1271.3, definitions, eCFR, Office of the Federal Register and Government Publishing Office. Paragraph (e): manufacture includes storage, labeling, packaging and distribution.
- 21 CFR 1271.370, Labeling, eCFR, Office of the Federal Register and Government Publishing Office. What must appear on an HCT/P label or accompany the product.
- 21 CFR 1271.270, Records, eCFR, Office of the Federal Register and Government Publishing Office. Paragraph (d): the 10-year retention period for covered establishments.
- UDI Basics, U.S. Food and Drug Administration. Device identifier, production identifier, and the two forms in which a UDI is printed.
- 21 CFR 801.3, device labeling definitions, eCFR, Office of the Federal Register and Government Publishing Office. Definition of lot or batch.
- Recalls (Biologics), U.S. Food and Drug Administration. FDA's description of a recall.
Ready to order for your clinic?
Complete the clinic intake. We review it, schedule a 20-minute call and most clinics place a first order within a week.
This page is general information for licensed providers and practice staff. It is not billing, coding, legal, or medical advice. Coverage rules vary by payer, region, setting, and date of service; confirm current policy before treating or billing.